Abstract 1166: <i>PTEN</i> loss and <i>ERG</i> over-expression as prognostic biomarkers in prostate cancer and identification of downstream biomarkers with potential therapeutic value
Julia L. Williams(Queen's University), Jeremy A. Squire(Universidade de São Paulo), Peter A. Greer(Queen's University), Paulo Nuin(Queen's University), Maisa Yoshimoto(University of Alberta)
Cited by 0
Related Papers
FISH analysis of 107 prostate cancers shows that PTEN genomic deletion is associated with poor clinical outcome
|British Journal of Cancer|2007|294
Absence of TMPRSS2:ERG fusions and PTEN losses in prostate cancer is associated with a favorable outcome
|Modern Pathology|2008|278
<i>PTEN</i> genomic deletion is associated with p‐Akt and AR signalling in poorer outcome, hormone refractory prostate cancer
|The Journal of Pathology|2009|210